A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa

The global increase in multidrug resistant (MDR) bacteria has led to phage therapy being refocused upon. A novel endolysin, LysPA26, containing a lysozyme-like domain, was screened against Pseudomonas aeruginosa in this study. It had activity against MDR P. aeruginosa without pretreatment with an ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Mingquan, Feng, Chunyan, Ren, Jie, Zhuang, Xuran, Zhang, Yan, Zhu, Yongzhang, Dong, Ke, He, Ping, Guo, Xiaokui, Qin, Jinhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326749/
https://www.ncbi.nlm.nih.gov/pubmed/28289407
http://dx.doi.org/10.3389/fmicb.2017.00293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326749/
https://www.ncbi.nlm.nih.gov/pubmed/28289407
http://dx.doi.org/10.3389/fmicb.2017.00293

Ejemplares similares